Citadel Advisors »

Achilles Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Achilles Therapeutics (ACHL) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Achilles Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Achilles Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Achilles Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $96k 109k 0.89
2023-09-30 $52k 58k 0.91
2023-06-30 $63k 67k 0.95
2023-03-31 $64k 67k 0.96
2022-12-31 $23k 25k 0.90
2022-06-30 $69k 28k 2.51
2022-03-31 $53k 18k 2.94
2021-12-31 $283k 57k 5.00
2021-03-31 $734k 39k 18.69